Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia

D. Kazmierski, M. L. Palomba, C. Barsigian

Open source

DOI
10.1155/2017/5183646
Published
2017
Container
Case Reports in Hematology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2017/5183646,
  title = {Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia},
  author = {D. Kazmierski and M. L. Palomba and C. Barsigian},
  year = {2017},
  journal = {Case Reports in Hematology},
  doi = {10.1155/2017/5183646},
  url = {https://doi.org/10.1155/2017/5183646}
}

RIS

TY  - JOUR
TI  - Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia
AU  - D. Kazmierski
AU  - M. L. Palomba
AU  - C. Barsigian
PY  - 2017
JO  - Case Reports in Hematology
DO  - 10.1155/2017/5183646
UR  - https://doi.org/10.1155/2017/5183646
ER  - 

APA

Kazmierski, D., Palomba, M. L., & Barsigian, C. (2017). Utility of MYD88 in the Differential Diagnosis and Choice of Second-Line Therapy in a Case of Nonsecretory Lymphoplasmacytic Lymphoma versus Free Light Chain Waldenstrom’s Macroglobulinemia. Case Reports in Hematology. https://doi.org/10.1155/2017/5183646

Source records